Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells

Lena Kastl1, Iain Brown, Andrew C Schofield

  • 1School of Medicine and Dentistry, College of Life Sciences and Medicine, University of Aberdeen, Medical School, Foresterhill, Aberdeen, AB25 2ZD, UK.

Insights

Investigating DNA methylation in breast cancer, this study found changes in the DNA methylation machinery are linked to docetaxel resistance. Epigenetic therapies may offer a strategy to overcome this resistance, but require further investigation.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Docetaxel is a key chemotherapy for breast cancer, but drug resistance mechanisms remain unclear.
  • DNA methylation, an epigenetic process regulating gene expression, is implicated in cancer development and chemotherapy resistance.

Purpose of the Study:

  • To explore the role of DNA methylation in docetaxel resistance in human breast cancer cell lines.
  • To investigate the impact of decitabine, a DNA methylation inhibitor, on docetaxel resistance.

Main Methods:

  • Established docetaxel-resistant MCF-7 and MDA-MB-231 breast cancer cell lines.
  • Treated cells with decitabine and assessed global methylation, DNA methyltransferase (DNMT) activity, and DNMT gene expression (DNMT1, DNMT3a, DNMT3b) via ELISA and qRT-PCR.
  • Evaluated cell viability using MTT assays.

Main Results:

  • Docetaxel resistance was associated with decreased DNMT activity and DNMT1/DNMT3b expression in both cell lines.
  • Decitabine reduced methylation and DNMT expression in resistant MDA-MB-231 cells but increased DNMT expression in resistant MCF-7 cells.
  • Decitabine enhanced docetaxel resistance in MCF-7 cells and sensitive parental lines, but not in resistant MDA-MB-231 cells.

Conclusions:

  • Alterations in the DNA methylation machinery correlate with docetaxel resistance in breast cancer.
  • The response to decitabine is cell-line specific, suggesting complex interactions in epigenetic regulation of drug resistance.
  • Further research into epigenetic therapies is crucial for overcoming chemotherapy resistance in various cancers.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...